DART: DUAL ANTI-CTLA-4 AND ANTI-PD-1 BLOCKADE IN RARE TUMORS
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Advanced Rare Tumors
-
Age: Between 18 years - 99 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
1. Patients must have histologically confirmed rare cancer. 2. No other prior malignancy is allowed except for the following: Adequately managed Stage I or II cancer from which the patient is currently in complete remission OR Any other cancer from which the patient has been disease free for one year OR Adequately managed Stage I or II follicular thyroid or prostate cancer
You may not be eligible for this study if the following are true:
-
1. Patients with active autoimmune disease 2. Patients with uncontrolled intercurrent illness
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.